Remove 2015 Remove Pharma Companies Remove Pharmacokinetics Remove Small Molecule
article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

Lanifibranor is believed to be the first drug candidate to be granted this status for the treatment of NASH since January 2015. Talking Medicine uses advanced AI to provide pharmaceutical companies with real-time data intelligence. Dolmatics – U.K.-based based Dotmatics Ltd.